Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial.
Reich
Kristian
K
Dermatologikum Hamburg, Hamburg, Germany. reich@dermatologikum.de
Signorovitch
James
J
Ramakrishnan
Karthik
K
Yu
Andrew P
AP
Wu
Eric Q
EQ
Gupta
Shiraz R
SR
Bao
Yanjun
Y
Mulani
Parvez M
PM